Jammu And Kashmir Headlines

Isothermal Nucleic Acid Amplification Technology Market worth $6.8 billion | MarketsandMarkets

 Breaking News
  • No posts were found

Isothermal Nucleic Acid Amplification Technology Market worth $6.8 billion | MarketsandMarkets

March 24
00:40 2023
Isothermal Nucleic Acid Amplification Technology Market worth $6.8 billion | MarketsandMarkets
The prominent players operating in INAAT market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland)
global isothermal nucleic acid amplification technology market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 9.2%

Isothermal Nucleic Acid Amplification Technology (INAAT) is a revolutionary, rapid, and cost-effective technology for amplifying and detecting nucleic acid targets. INAAT is being explored for a wide range of applications including diagnostic testing (e.g., detection of infectious diseases and cancer), food safety, and environmental monitoring. The isothermal nucleic acid amplification technology market is projected to witness remarkable growth in the near future, owing to increasing government initiatives in the field of diagnostics, rising prevalence of infectious diseases, and technological advancements in the field. Moreover, increasing adoption of INAAT by healthcare providers and pharmaceutical companies to reduce costs and improve the accuracy of diagnostics is expected to drive the growth of the market.

Isothermal Nucleic Acid Amplification Technology Market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 9.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of the market is attributed the growing funding initiatives for molecular diagnostics & infectious diseases, and recent launches of INAAT consumables by prominent market players. However, the unfavorable reimbursement scenario for in vitro diagnostic tests is a major factor restraining market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839

Browse in-depth TOC on “Isothermal Nucleic Acid Amplification Technology Market” 

226 – Tables 

46 – Figures 

235 – Pages

Assay, kits and reagents segment accounted for the largest share of the INAAT market

Based on the product, the INAAT market is segmented into assay, kits, and reagents, and systems. The assay, kits, and reagents segment accounted for the largest share in 2022, which is attributed to increasing demand of infectious disease diagnostic tests, infectious diseases-the continuous launch of newer, faster, and more reliable POC products and extensive use of INAAT products.

LAMP segment accounted for the largest share of the INAAT market

Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. The loop-mediated isothermal amplification (LAMP) segment dominated the market in 2022. The largest share of this segment is attributed to the prominent players in the market offering LAMP kits and rising of LAMP kits in infectious diseases diagnostics.

Infectious disease diagnosis segment accounted for the largest application segment of the market

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are launch of INAAT covid-19 kits and extensive use of INAAT in diagnosis of Hepatitis and HIV.

Hospital segment accounted for the largest share of the global INAAT market

Based on the end user, the market is divided into hospitals, reference laboratories, academic and research institutes, and other end users. The hospital segment is expected to account for the largest share of the INAAT market in 2022. This is owing to high demand for fast test and kits, increase in patient population, extensive use of moleucular diagnostic kits and need for early doagnostic solutions.

North America accounted for the largest share of the market

North America is expected to account for the largest share of the global INAAT market, followed by Europe in 2022. The largest share of the North American market is attributed to the presence of a leading market players, growing burden of infectious diseases and availability of R&D funding for molecular diagnostics.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=839

Isothermal Nucleic Acid Amplification Technology Market Dynamics:

Drivers:

  1. Recent launches of INAAT consumables by prominent market players
  2. Growing funding initiatives for molecular diagnostics & infectious disease diagnostics
  3. High prevalence of infectious diseases

Restraints:

  1. Unfavorable reimbursement scenario for in vitro diagnostic tests

Opportunities:

  1. INAAT tests as point-of-care tools
  2. Start-ups focusing on INAAT

Challenges:

  1. Dominance of PCR

Key Market Players:

The prominent players operating in INAAT market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).

Recent Developments

  • In May 2022, Hologic, Inc. (US) received CE marking for two new molecular assays, Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay, expanding its transplant pathogen monitoring menu on the Panther Fusion system.
  • In December 2021, Hologic, Inc. (US) launched Panther Trax, which offers full automation to meet high-volume testing demands and will be commercially available in the US, Europe, Canada, Australia, and New Zealand.
  • In September 2020, Abbott (US) received approval from Health Canada for the ID NOW rapid COVID-19 testing device for use in Canada.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=839

Isothermal Nucleic Acid Amplification Technology Market- Report Highlights:

  • Additional points, such as trends/disruptions impacting customers’ businesses, pricing analysis, value chain analysis, ecosystem analysis, regulatory landscape, Porter’s five forces analysis, key conferences & events in 2023–2024, technology analysis, key stakeholders and buying criteria, and patent analysis have been added to the market overview chapter.
  • The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This will help analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.
  • Recent developments help understand market trends and growth strategies adopted by players in the market.
  • Tracking the product portfolios of prominent market players helps analyze the major products in the isothermal nucleic acid amplification technology market. The new edition of the report provides an updated product portfolio of the companies profiled.
  • The new edition of the report provides an updated product portfolio of the companies profiled in the report. A total of 25 companies have been profiled.
  • Key market strategies, market share analysis for 2022, revenue share analysis of key market players from 2020 to 2022, and competitive leadership mapping have been added to the competitive landscape section of the report.
  • The new version of the report includes competitive leadership mapping for companies operating in the isothermal nucleic acid amplification technology market. This new section is an output of a comprehensive study of the key vendors offering INAAT products. The top 25 vendors were shortlisted from a list of 50+ vendors, and these were evaluated based on market shares/rankings and product footprint.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/isothermal-nucleic-acid-amplification-technologies-inaat-market-839.html